XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flow from operating activities    
Net loss $ (5,364) $ (3,968)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 289 338
Amortization of right of use assets 38 56
Depreciation 36 99
(Increase) decrease in operating assets    
Prepaid drug product for testing (303) (322)
Other current assets (646) (42)
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses (23) (328)
Lease liabilities (42) (56)
Net cash used in operating activities (6,015) (4,223)
Cash flow from financing activities    
Net proceeds from sale of common stock 0 19,411
Net proceeds from exercise of warrants 0 914
Net cash provided by financing activities 0 20,325
Net (decrease) increase in cash (6,015) 16,102
Cash, beginning of period 20,426 1,004
Cash, end of period $ 14,411 $ 17,106